Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Charles Perkins Centre, University of Sydney, Sydney, Australia.
Diabetes Care. 2024 Jan 1;47(1):66-70. doi: 10.2337/dc23-0781.
We aimed to assess whether remission of type 2 diabetes (T2D) could be achieved with a low-energy total diet replacement (TDR) in an Australian primary care setting.
Individuals aged 20-65 years with T2D duration up to 6 years, BMI >27.0 kg/m2, and not treated with insulin were prescribed a 13-week low-energy TDR (Optifast; Nestlé Health Science) followed by 8-week structured food reintroduction and 31-week supported weight maintenance. The primary outcome was T2D remission at 12 months.
A total of 155 participants comprised the intention-to-treat population. At 12 months, T2D remission was achieved in 86 (56%) participants, with a mean adjusted weight loss of 8.1% (95% CI 7.2-9.1). Two serious adverse events requiring hospitalization related to the study intervention were reported.
At 12 months T2D remission was achieved for one in two Australian adults in a primary care setting.
我们旨在评估在澳大利亚初级保健环境中,低能量总膳食替代(TDR)是否可实现 2 型糖尿病(T2D)的缓解。
患有 T2D 持续时间长达 6 年、BMI>27.0 kg/m2 且未接受胰岛素治疗的 20-65 岁个体,被规定进行为期 13 周的低能量 TDR(Optifast;雀巢健康科学公司),随后进行 8 周的结构化食物重新引入和 31 周的支持性体重维持。主要结局是 12 个月时的 T2D 缓解。
共有 155 名参与者构成意向治疗人群。在 12 个月时,86 名(56%)参与者达到 T2D 缓解,平均调整后体重减轻 8.1%(95%CI 7.2-9.1)。报告了两例与研究干预相关的需住院治疗的严重不良事件。
在 12 个月时,在初级保健环境中,有二分之一的澳大利亚成年人实现了 T2D 缓解。